Insider · CIK 0001861840
Christine Coyne
Files at ITRM (Iterum Therapeutics plc). First filing -, latest -.
Christine Coyne files SEC Form 4 as officer at ITRM (Iterum Therapeutics plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christine Coyne has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | ITRM Iterum Therapeutics plc | AGrant or award Share Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Jul 3, 2025 |
Questions about Christine Coyne
Answered from the filings on this page, as of the latest one.
Is Christine Coyne buying or selling?
Christine Coyne has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christine Coyne's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine Coyne has 0.
Where does Christine Coyne file Form 4?
Christine Coyne has filed Form 4 at ITRM (Iterum Therapeutics plc) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.